Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris. 1990

H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
Department of Cardiology, Princess Margaret Hospital, Christchurch, New Zealand.

A pilot study was performed to assess the short-term effects of intravenous captopril on anginal threshold and systemic and coronary hemodynamics in patients with stable angina pectoris. Twelve patients with documented coronary artery disease, stable angina pectoris and normal left ventricular function were studied by an incremental atrial pacing stress test before and after intravenous captopril (n = 8) or placebo (n = 4). There were no significant differences in the extent of coronary disease or left ventricular function between the 2 groups and resting plasma-renin levels were normal. Captopril increased the time to angina (14 +/- 4 to 9 +/- 5 minutes, p less than 0.05), increased heart rate at development of angina (126 +/- 7 to 142 +/- 7 beats/min, p less than 0.05) and tended to increase coronary blood flow (229 +/- 154 to 296 +/- 259 ml/min, p = 0.11) and decrease coronary vascular resistance (53 +/- 10 to 47 +/- 3 dynes s cm-5/1,000, p = 0.11) at peak stress without alteration in systemic hemodynamics. No significant changes were seen after placebo administration. Therefore, intravenous captopril appears to cause a short-term increase of coronary vascular reserve, and anginal threshold in patients with chronic stable angina. This effect appears to be independent of inhibition of the systemic renin-angiotensin system or systemic hemodynamic changes.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac

Related Publications

H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
January 1992, Archivos del Instituto de Cardiologia de Mexico,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
January 1982, Rational drug therapy,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
February 1989, The American journal of cardiology,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
February 1991, Kardiologiia,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
August 2011, Nature reviews. Cardiology,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
September 1983, The American journal of cardiology,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
May 1989, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
March 1990, Casopis lekaru ceskych,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
January 2002, American journal of cardiovascular drugs : drugs, devices, and other interventions,
H Ikram, and C J Low, and T Shirlaw, and C M Webb, and A M Richards, and I G Crozier
January 1995, European journal of clinical pharmacology,
Copied contents to your clipboard!